Lucamzi

Product NDC
85006-4663
Requested package NDC
85006-4663-1
11-digit product format
850064663
Labeler code
85006
Product ID
85006-4663_d8337b8e-4cb3-49a8-a95f-723dc3d37ebb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ranibizumab
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Labeler
Valorum Biologics LLC
Application
BLA761187
Marketing category
BLA
Marketing start
2026-10-27
Substance
RANIBIZUMAB
Active strength
10 mg/mL
Pharmacologic classes
Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Lucamzi
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RANIBIZUMAB10 mg/mL

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761187Lucamziranibizumab-blrz351(k) BiosimilarRx2026-10-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
85006-4663-1850064663011 VIAL, SINGLE-DOSE in 1 CARTON (85006-4663-1) / .5 mL in 1 VIAL, SINGLE-DOSE2026-10-27NoNoCurrent